The largest database of trusted experimental protocols

Micro bca protein assay kit

Manufactured by Thermo Fisher Scientific
Sourced in United States, United Kingdom, France, Germany, Italy, Spain, Japan, China, Canada, Australia, Switzerland, Denmark, Austria

The Micro BCA Protein Assay Kit is a colorimetric detection method for the quantification of protein concentrations. The kit utilizes the bicinchoninic acid (BCA) reaction to determine the total protein content of a sample.

Automatically generated - may contain errors

1 094 protocols using micro bca protein assay kit

1

Micro BCA Protein Quantitation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein concentration was measured by a MicroBCA Protein Assay Kit (Thermo Scientific, Pierce Biotechnology, USA) using a spectrophotometer (UVM340, ASYS). The Thermo Scientific™ Micro BCA™ Protein Assay Kit is a detergent-compatible bicinchoninic acid formulation for the colorimetric detection and quantitation of total protein. An adaptation of the Thermo Scientific™ BCA Protein Assay Kit (Product No. 23225), the Micro BCA Kit has been optimized for use with dilute protein samples (0.5–20 µg/mL). The unique patented method uses bicinchoninic acid (BCA) as the detection reagent for Cu+1, which is formed when Cu+2 is reduced by protein in an alkaline environment. A purple-colored reaction product is formed by the chelation of two molecules of BCA with one cuprous ion (Cu+1). This water-soluble complex exhibits a strong absorbance at 562 nm that is linear with increasing protein concentrations. The result is an extremely sensitive colorimetric protein assay in a test tube or microplate assay format.
+ Open protocol
+ Expand
2

Protein Quantification of EV Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein concentration of EV samples from UC and dUC was quantified using the Micro BCA™ Protein Assay Kit (Thermo Fisher Scientific, MA, USA), following manufacturer’s instructions. Protein quantification of EV samples isolated using Exoquick was performed with Pierce™ BCA Protein Assay Kit (Thermo Fisher Scientific, MA, USA) (following manufacturers’ protocol) since EXO EVs contain high protein concentration, often out of the limit of quantification of Micro BCA™ Protein Assay Kit. Protein was quantified in a FLUOstar Omega microplate reader (BMG LABTEC, Ortenberg, German) at 562 nm.
+ Open protocol
+ Expand
3

MMP-12 Levels in Spinal Nerves

Check if the same lab product or an alternative is used in the 5 most similar protocols
MMP-12 concentrations in the left L4, L5, and L6, and right L5 spinal nerves, harvested from rats euthanized by carbon dioxide exposure, were determined using an MMP-12 activity assay (AS-71157, AnaSpec, CA, USA). Specimens were homogenized in assay buffer containing 0.1% Triton X-100 and centrifuged at 10000 ×g for 15 min at 4°C. The supernatant obtained was further diluted in assay buffer by 10-fold. MMP-12 concentrations were calculated relative to a human MMP-12 catalytic domain (1 μg/ml, AS-55525, Anaspec, CA, USA) standard curve. 1 mM 5-FAM-Pro-Leu-OH was used as a 5-FAM fluorescence reference standard for instrument calibration. 50 μl of each diluted spinal nerve specimen supernatant, human MMP-12 catalytic domain dilutions, 5-FAM-Pro-Leu-OH dilutions, and a substrate control containing assay buffer only were added to a 96-well plate. 50 μl of MMP-12 substrate was added to each well before incubating at 37°C for 45 min. Thereafter, 50 μl stop solution was added in all wells, and the fluorescence intensity at Ex/Em = 490/520 nm was measured (PHERAstar fluorimeter, BGM Labtech, Germany). Total protein for each sample was measured relative to an albumin standard curve, using a Micro BCA Protein Assay Kit (Micro BCA Protein Assay Kit, Thermo Scientific, MA, USA).
+ Open protocol
+ Expand
4

Assessing Anticancer Drug-Induced Lipid Peroxidation

Check if the same lab product or an alternative is used in the 5 most similar protocols
After the appropriate cell growth, cardiomyocytes and hepatocytes were seeded in a 24-well plate and allowed to grow for one day. Lipid peroxidation, having a key role in the etiopathogenesis of the cardiac and hepatic damage of anticancer drugs, was induced by incubating cells with Doxorubicin or Trastuzumab (200 nM) for 6 h; anti-oxidant studies were performed by a pre-incubation for 4h with unformulated or formulated CoQ10-loaded nano-carriers and subsequently with treatments with anticancer drugs. After treatments, cells were washed three times with cold PBS, harvested with 0.25% v/v Trypsin and centrifuged at 1000 ×g for 10 min. The supernatant was discarded and the cell pellet sonicated in cold PBS. After a centrifugation step at 800 ×g for 5 min, we quantified malondialdehyde (MDA) by using a commercial kit with a spectrophotometer according to the manufacturer’s protocols (Sigma Aldrich, Milan, Italy).32 (link) We measured the protein content of the cell homogenates using the Micro BCA protein assay kit (Pierce, Thermo Fisher, Milan, Italy) according to kit instructions.
+ Open protocol
+ Expand
5

Lipid Peroxidation in Heart Failure and Chemo-Resistance

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipid peroxidation is a key player in heart failure and chemo-resistance phenomena. Co-cultures of cardiomyocytes/hPBMCs and breast cancer cells/hPBMCs were untreated (control) or treated with ipilimumab (100 nM) for 6 h under high glucose, low glucose, shifting from high glucose to low glucose, or treated with empagliflozin (500 nM) under high glucose. After treatments, cells were washed three times with cold PBS, harvested with 0.25% v/v Trypsin, and centrifuged at 1000× g for 10 min. The supernatant was discarded and the cell pellet sonicated in cold PBS. After a centrifugation step at 800× g for 5 min, we quantified malondialdehyde (MDA) by using a commercial kit with a spectrophotometer according to the manufacturer’s protocols (Sigma Aldrich, Milan, Italy) [79 (link)]. We measured the protein content of the cell homogenates using the Micro BCA protein assay kit (Pierce, Thermo Fisher, Milan, Italy) according to the kit instructions.
+ Open protocol
+ Expand
6

Anticancer Drug-Induced Cardiotoxicity Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Intracellular reactive oxygen species and lipid peroxidation are key mediators of anticancer drug-induced cardiovascular diseases, including myocarditis (29 (link)). In brief, after treatments described in paragraph 2.1, cardiomyocytes were washed three times with cold PBS, harvested with 0.25%v/v Trypsin and centrifuged at 1,000×g for 10 min. The supernatant was discarded and the cell pellet sonicated in cold PBS. After a centrifugation step at 800×g for 5 min, we quantified intracellular ROS and two markers of lipid peroxidation called malondialdehyde (MDA) and 4-Hydroxynonenal (4-HNA) through commercial kit with a spectrophotometer according to the manufacturer's protocols (Sigma Aldrich, Milan, Italy). According to the kit instructions, the total protein content of cardiac cell homogenates was quantified through Micro BCA protein assay kit (Pierce, Thermo Fisher, Milan, Italy).
+ Open protocol
+ Expand
7

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For protein extraction, RIPA lysis buffer system for mammalian cell and tissue lysis buffer were purchased from SantaCruz biotechnology (Dallas, TX, USA) (Catalog No. sc-24948). Protein extraction was performed using the product manual and concentrations were measured by Micro BCA Protein Assay Kit (Life Technologies cat no. 23235) at 562 nm wave length according to the product manual. Equal amounts of soluble proteins (30–50 μg) were mixed with NuPAGE sample reducing agent (Life technologies) and heat denatured at 95ºc for 5 min and loaded on 10–12% Bis-Tris pre made gels (Life technologies) and transferred to 0.45 μm PVDF membrane (Thermo Scientific). After blocking in 5% non-fat dry milk or BSA in 1 × TBS-T for 1 h and probing with a specific primary antibody and a horseradish peroxidase-conjugated secondary antibody, the protein bands were detected by chemiluminescence (Supersignal, Pierce) and CCD camera. Protein loading was normalized by using anti-β actin antibody.
+ Open protocol
+ Expand
8

Controlled Osteocalcin Release via Nanochannel Capsules

Check if the same lab product or an alternative is used in the 5 most similar protocols
Osteocalcin (AnaSpec Inc., Fremont, CA, USA) release was performed with similar nanochannel capsules as above [22 (link)]. The reservoir was loaded with 250 μL of Osteocalcin solution at a concentration of 400 μg/mL in phosphate-buffered saline (PBS). 3 and 5 nm (n = 3 each) nanochannel membranes were used. Each capsule was immersed in a borosilicate glass bottle containing 5 mL of Millipore water. 500 μL of samples were taken every 12 h for 10 days. The amount of sample removed was replaced each time with the buffer solution. Hormone concentration was determined with a micro BCA protein assay kit (Life Technologies, Carlsbad, CA, USA) using bovine serum albumin as a standard.
+ Open protocol
+ Expand
9

Subcellular Fractionation of RA-Differentiated SHSY5Y and SCG Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytosolic extracts were prepared from 14-day-old RA-differentiated SHSY5Y cells or 2-week-old compartmentalized SCG cultures using the NE-PER™ Nuclear and Cytoplasmic Extraction Kit (Life Technologies) according to the manufacturer’s instructions. The mitochondrial fractions were isolated from 2-week-old compartmentalized SCG cultures using the Mitochondria Isolation Kit for Cultured Cell according to the manufacturer’s protocol. The cell-body and axonal compartments were processed separately. Protein concentration was determined using the Micro BCA Protein Assay Kit (Life Technologies).
+ Open protocol
+ Expand
10

Controlled Osteocalcin Release via Nanochannel Capsules

Check if the same lab product or an alternative is used in the 5 most similar protocols
Osteocalcin (AnaSpec Inc., Fremont, CA, USA) release was performed with similar nanochannel capsules as above [22 (link)]. The reservoir was loaded with 250 μL of Osteocalcin solution at a concentration of 400 μg/mL in phosphate-buffered saline (PBS). 3 and 5 nm (n = 3 each) nanochannel membranes were used. Each capsule was immersed in a borosilicate glass bottle containing 5 mL of Millipore water. 500 μL of samples were taken every 12 h for 10 days. The amount of sample removed was replaced each time with the buffer solution. Hormone concentration was determined with a micro BCA protein assay kit (Life Technologies, Carlsbad, CA, USA) using bovine serum albumin as a standard.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!